WaferGen Nets $6.7M from Direct Offering | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – WaferGen Biosystems said after the close of the market on Thursday that it has closed on its $7.2 million registered direct offering.

Net proceeds from the offering totaled about $6.7 million. The amount raised includes $1 million from Chairman and CEO Alnoor Shivji and about $500,000 in aggregate from four other board members.

Proceeds will be used for general working capital purposes and continued commercialization of its SmartChip Real-Time PCR System.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: vervet genome, tandem repeats affect gene expression in great apes, and more.

Wired's Sarah Zhang writes that the fight over who developed the CRISPR/Cas9 genome editing tool first underscores the history of parallel discoveries in science.

Recent research indicates that the benefit of having a number of scientists all living and working in a certain area is eroding.

Tomas Lindahl, Paul Modrich, and Aziz Sancar share this year's Nobel Prize in Chemistry for their studies of DNA repair mechanisms.